argenx SE reported $47M in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
AstraZeneca USD 32.24B 1.68B Jun/2026
Genmab DKK 5.35B 5.2B Mar/2026
GlaxoSmithKline GBP 18.24B 818M Jun/2026
GRIFOLS EUR 9.24B 723M Sep/2026
Hikma Pharmaceutical USD 1.6B 46M Dec/2025
Lakefront Biotherapeutics EUR 6.44M 480K Mar/2026
Qiagen NV USD 1.64B 2.94M Jun/2026
UCB EUR 3.03B 12M Dec/2024